Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
William Hartzel | SVP Bioservices | 2024-04-07 | 665 | $2.29 | $1.52kSell |
Coleen Glessner | EVP Quality Ethics and CPL | 2024-04-07 | 585 | $2.29 | $1.34kSell |
William Hartzel | SVP Bioservices | 2024-03-05 | 346 | $3.41 | $1.18kSell |
Richard S. Lindahl | EVP Chief Financial Officer | 2024-03-01 | 684 | $3.39 | $2.32kSell |
Jennifer Lynne Fox | EVP Ext Aff GC Corp Sec | 2024-03-01 | 703 | $3.39 | $2.38kSell |
Paul Anthony Williams | SVP Products Business | 2024-03-01 | 137 | $3.39 | $464.43Sell |
Coleen Glessner | EVP Quality Ethics and CPL | 2024-03-01 | 381 | $3.39 | $1.29kSell |
Paul Anthony Williams | SVP Products Business | 2024-02-29 | 450 | $3.23 | $1.45kSell |
Jennifer Lynne Fox | EVP Ext Aff GC Corp Sec | 2024-02-29 | 4,103 | $3.23 | $13.25kSell |
Richard S. Lindahl | EVP Chief Financial Officer | 2024-02-29 | 9,037 | $3.23 | $29.19kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Fuad Elhibri | 49.29% | 25,733,310 | $58.93M | Insider |
Blackrock Inc | 18.00% | 9,399,197 | $21.52M | Institution |
Intervac LLC | 8.32% | 4,344,250 | $9.95M | Insider |
Vanguard Group Inc | 5.70% | 2,974,638 | $6.81M | Institution |
Charles Schwab Investment Management Inc | 5.51% | 2,873,984 | $6.58M | Institution |
Biopharm LLC | 4.34% | 2,265,043 | $5.19M | Insider |
Millennium Management LLC | 4.01% | 2,095,662 | $4.80M | Institution |
Robert Calvin Myers | 3.71% | 1,934,849 | $4.43M | Insider |
Hotchkis Wiley Capital Management LLC | 3.16% | 1,647,243 | $3.77M | Institution |
Biovac LLC | 3.06% | 1,599,155 | $3.66M | Insider |